BOYER GIVES $10M TO YALE MED SCHOOLGenentech founder Dr. Herbert Boyer and his wife, Gracie, havegiven $10 million to Yale University toward the building of the$38 million Center for Molecular Medicine.
It is the largest individual gift the medical school has received,the university said.
The research center will be named for the Boyers, Yale said.Herbert Boyer, who also is chairman of the Dean's Council of theSchool of Medicine, was a post-doctoral fellow at Yale from1963 to 1966.
CIBA, TANOX TO TEST MAb AGAINST HIV
Ciba-Geigy Ltd. of Switzerland and Tanox Biosystems Inc. ofHouston this month will start testing the safety of theirmonoclonal antibody against the HIV gp 120 protein in 12volunteer AIDS patients in Zurich, the companies announcedlast week.
Ciba and Tanox signed a collaboration agreement in 1989 tojointly develop the AIDS therapeutic. Under the terms of theagreement, Ciba is funding the development and will holdworldwide marketing rights. Tanox will receive royalties onsales.
SOMATOGEN, KABI INK CO-DEVELOPMENT DEAL
Somatogen Inc. on Thursday said it has signed an exclusiveagreement with Kabi Pharmacia AB of Sweden to performclinical development and marketing of the Boulder, Colo.,company's recombinant hemoglobin-based blood substitute inSweden, Denmark, Norway, Finland and Iceland.
BAXTER TO BOOST QUADRA INVESTMENT
Quadra Logic Technologies Inc. said Baxter Healthcare Corp.,QLT's partner in a joint research program to develop light-activated drugs, has agreed to increase its investment in theproject. QLT, of Vancouver, British Columbia, declined to revealthe size of the investment in the project to develop QLT'sphotosensitizer benzoporphyrin derivative to inactivate virusesin human blood donations.
TSI FILES REGISTRATION STATEMENT
TSI Corp. of Worcester, Mass., last week said it had filed withthe Securities and Exchange Commission a registrationstatement for 4.2 million shares of common stock issuable onexercise of the company's Class B, C, D and E warrants. Thecompany, which develops advanced toxicology tests anddisease models, said it would exercise its right to redeem B, Cand E warrants if certain conditions are met.
NORTH AMERICAN VACCINE SUES CYANAMID
North American Vaccine Inc. said it and the Canadiangovernment have filed a patent infringement suit againstAmerican Cyanamid Co. and its wholly owned subsidiary,Praxis Biologics Inc., as a result of their manufacture and saleof HibTiter vaccine for Haemophilus influenza type b. The suitalleges that Cyanamid and Praxis have infringed a U.S. patentowned by the Canadian government and exclusively licensed toNorth American Vaccine of Beltsville, Md.
(c) 1997 American Health Consultants. All rights reserved.